M C Iannuzzi

1.3k total citations
28 papers, 945 citations indexed

About

M C Iannuzzi is a scholar working on Pulmonary and Respiratory Medicine, Physiology and Molecular Biology. According to data from OpenAlex, M C Iannuzzi has authored 28 papers receiving a total of 945 indexed citations (citations by other indexed papers that have themselves been cited), including 17 papers in Pulmonary and Respiratory Medicine, 12 papers in Physiology and 6 papers in Molecular Biology. Recurrent topics in M C Iannuzzi's work include Sarcoidosis and Beryllium Toxicity Research (11 papers), Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis (8 papers) and Cystic Fibrosis Research Advances (5 papers). M C Iannuzzi is often cited by papers focused on Sarcoidosis and Beryllium Toxicity Research (11 papers), Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis (8 papers) and Cystic Fibrosis Research Advances (5 papers). M C Iannuzzi collaborates with scholars based in United States, Italy and United Kingdom. M C Iannuzzi's co-authors include Benjamin A. Rybicki, Mary Maliarik, Marcie Major, John Popovich, Robert C. Elston, Courtney Gray‐McGuire, A. BASHA, Reda E. Girgis, Albert M. Levin and Sudha K. Iyengar and has published in prestigious journals such as Nucleic Acids Research, Nature Genetics and American Journal of Respiratory and Critical Care Medicine.

In The Last Decade

M C Iannuzzi

27 papers receiving 912 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
M C Iannuzzi United States 18 621 500 192 138 136 28 945
Şenol Kobak Türkiye 15 258 0.4× 314 0.6× 118 0.6× 92 0.7× 34 0.3× 88 796
Michio Shigematsu Japan 14 658 1.1× 300 0.6× 58 0.3× 85 0.6× 35 0.3× 29 814
Shuzo Yoshida Japan 15 208 0.3× 44 0.1× 90 0.5× 271 2.0× 65 0.5× 40 810
David Weldon United States 11 124 0.2× 343 0.7× 43 0.2× 31 0.2× 429 3.2× 22 1.4k
Elif Karakoç-Aydıner Türkiye 18 150 0.2× 249 0.5× 73 0.4× 92 0.7× 55 0.4× 72 900
Michael H. Ellman United States 15 213 0.3× 103 0.2× 96 0.5× 154 1.1× 22 0.2× 24 972
Catherine R. Weiler United States 17 95 0.2× 141 0.3× 66 0.3× 76 0.6× 58 0.4× 51 813
Costantino Botsios Italy 15 74 0.1× 120 0.2× 132 0.7× 73 0.5× 65 0.5× 26 717
Lin Liao China 14 215 0.3× 239 0.5× 83 0.4× 47 0.3× 136 1.0× 57 689
D L Brown United Kingdom 15 198 0.3× 57 0.1× 78 0.4× 191 1.4× 71 0.5× 32 710

Countries citing papers authored by M C Iannuzzi

Since Specialization
Citations

This map shows the geographic impact of M C Iannuzzi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by M C Iannuzzi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites M C Iannuzzi more than expected).

Fields of papers citing papers by M C Iannuzzi

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by M C Iannuzzi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by M C Iannuzzi. The network helps show where M C Iannuzzi may publish in the future.

Co-authorship network of co-authors of M C Iannuzzi

This figure shows the co-authorship network connecting the top 25 collaborators of M C Iannuzzi. A scholar is included among the top collaborators of M C Iannuzzi based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with M C Iannuzzi. M C Iannuzzi is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Williams, Susan, M C Iannuzzi, & Sarah Prior. (2025). Using Healthcare Redesign to Identify Medication Management Issues in Parkinson’s Disease. Pharmacy. 13(1). 13–13.
2.
Lareau, Caleb A., Indra Adrianto, Christopher J. Lessard, et al.. (2017). Polygenic risk assessment reveals pleiotropy between sarcoidosis and inflammatory disorders in the context of genetic ancestry. Genes and Immunity. 18(2). 88–94. 16 indexed citations
3.
Levin, Albert M., M C Iannuzzi, Courtney G. Montgomery, et al.. (2012). Association of ANXA11 genetic variation with sarcoidosis in African Americans and European Americans. Genes and Immunity. 14(1). 13–18. 50 indexed citations
4.
Rybicki, Benjamin A., Albert M. Levin, Paul McKeigue, et al.. (2010). A genome-wide admixture scan for ancestry-linked genes predisposing to sarcoidosis in African-Americans. Genes and Immunity. 12(2). 67–77. 32 indexed citations
5.
Iannuzzi, M C & Benjamin A. Rybicki. (2007). Genetics of Sarcoidosis: Candidate Genes and Genome Scans. Proceedings of the American Thoracic Society. 4(1). 108–116. 50 indexed citations
6.
Rybicki, Benjamin A., Ritwik Sinha, Sudha K. Iyengar, et al.. (2007). Genetic linkage analysis of sarcoidosis phenotypes: the sarcoidosis genetic analysis (SAGA) study. Genes and Immunity. 8(5). 379–386. 38 indexed citations
7.
Iannuzzi, M C, Sudha K. Iyengar, Courtney Gray‐McGuire, et al.. (2005). Genome-wide search for sarcoidosis susceptibility genes in African Americans. Genes and Immunity. 6(6). 509–518. 76 indexed citations
8.
Rybicki, Benjamin A., Mary Maliarik, Laila Poisson, & M C Iannuzzi. (2004). Sarcoidosis and granuloma genes: a family-based study in African-Americans. European Respiratory Journal. 24(2). 251–257. 29 indexed citations
9.
Rybicki, Benjamin A., Marcie Major, Mary Maliarik, et al.. (2001). Familial Risk Ratio of Sarcoidosis in African-American Sibs and Parents. American Journal of Epidemiology. 153(2). 188–193. 73 indexed citations
10.
Afzal, Adeel, et al.. (2000). Myocarditis and pericarditis with tamponade associated with disseminated tuberculosis.. PubMed. 16(4). 519–21. 18 indexed citations
11.
Ismeno, Gennaro, Attilio Renzulli, Antonio Carozza, et al.. (1999). Intravascular hemolysis after mitral and aortic valve replacement with different types of mechanical prostheses. International Journal of Cardiology. 69(2). 179–183. 31 indexed citations
12.
Rybicki, Benjamin A., Mary Maliarik, Cathryn H. Bock, et al.. (1999). The Blau syndrome gene is not a major risk factor for sarcoidosis.. PubMed. 16(2). 203–8. 31 indexed citations
13.
Rybicki, Benjamin A., et al.. (1998). Epidemiology, demographics, and genetics of sarcoidosis.. PubMed. 13(3). 166–73. 89 indexed citations
14.
Girgis, Reda E., A. BASHA, Mary Maliarik, John Popovich, & M C Iannuzzi. (1995). Cytokines in the Bronchoalveolar Lavage Fluid of Patients With Active Pulmonary Sarcoidosis. American Journal of Respiratory and Critical Care Medicine. 152(1). 71–75. 60 indexed citations
15.
McDonald, Marie, Soumitra Ghosh, Arthur A. Glatfelter, et al.. (1994). A disease locus for hereditary haemorrhagic telangiectasia maps to chromosome 9q33–34. Nature Genetics. 6(2). 197–204. 120 indexed citations
16.
Iannuzzi, M C, Nobuhiro Hidaka, Michael Boehnke, et al.. (1991). Analysis of the relationship of von Willebrand disease (vWD) and hereditary hemorrhagic telangiectasia and identification of a potential type IIA vWD mutation (IIe865 to Thr).. PubMed. 48(4). 757–63. 39 indexed citations
17.
Iannuzzi, M C, Robert C. Stern, FS Collins, et al.. (1991). Two frameshift mutations in the cystic fibrosis gene.. PubMed. 48(2). 227–31. 38 indexed citations
18.
Dean, Michael, Jennifer Lynch, Giovanni Romeo, et al.. (1990). Prenatal diagnosis and linkage disequilibrium with cystic fibrosis for markers surrounding D7S8. Human Genetics. 85(3). 275–8. 2 indexed citations
19.
Dean, Michael, Claudia Stewart, Anjanette Perry, et al.. (1989). Genetic Markers for Oncogenes, Growth Factors, and Cystic Fibrosis. Hämatologie und Bluttransfusion. 32. 360–365. 1 indexed citations
20.
Konkle, Barbara A., S. Kim, M C Iannuzzi, et al.. (1987). SacI RFLP in the human von Willebrand factor gene. Nucleic Acids Research. 15(16). 6766–6766. 20 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Şenol Kobak Breakdown of academic impact, for papers by Michio Shigematsu Breakdown of academic impact, for papers by Shuzo Yoshida Breakdown of academic impact, for papers by David Weldon Breakdown of academic impact, for papers by Elif Karakoç-Aydıner Breakdown of academic impact, for papers by Michael H. Ellman Breakdown of academic impact, for papers by Catherine R. Weiler Breakdown of academic impact, for papers by Costantino Botsios Breakdown of academic impact, for papers by Lin Liao Breakdown of academic impact, for papers by D L Brown
Rankless by CCL
2026